19 June 2017

As of 1 July 2017, Werner Koopman from the Dept. of Biochemistry. theme Mitochondrial diseases is appointed as Editor of the International Journal of Biochemistry and Cell Biology (IJBCB) of Elsevier.

He will edit a special section of the journal focusing on organelles. Topics of interest for IJBCB include, but are not limited to: mechanistic studies of cells, cell organelles, subcellular molecular pathways and metabolism, novel insights into disease pathogenesis, nanotechnology with implication to biological and medical processes, genomics and bioinformatics.

Website Elsevier IJBCB: link

Related news items


Towards a better understanding of Leigh Syndrome pathology and intervention published in Brain

8 December 2021 Melissa van de Wal and colleagues recently published a comprehensive review in the journal Brain on how Ndufs4 knockout mouse models have been used to unravel the pathomechanism of Leigh Syndrome. read more

New genetic defect links cell biology and protein glycosylation

10 November 2021 Peter Linders, Dirk Lefeber and Geert van den Bogaart together with international colleagues have recently reported on novel cell biological insights, by identifying a genetic disorder in syntaxin-5 which allowed to unravel a new mechanism regulating intracellular transportation. read more

Willeke Daamen ratified as ETRS board member

3 November 2021 Willeke Daamen, theme Reconstructive and regenerative medicine appointed as board member of The European Tissue Repair Society (ETRS). read more

Werner Koopman 25 years at Radboudumc celebrating online

8 July 2020 Werner Koopman completed his 25 years at Radboudumc. Biochemistry sent him a cake at home and celebrated this special moment during COVID-19 in a unique way. read more

Grant to study mitochondrial morphofunction in Parkinson’s disease

14 March 2019 Werner Koopman, theme Mitochondrial diseases, received 400,000 euro as a member of the PD-MitoQUANT consortium. The latter is an EU-funded Innovative Medicines Initiative research project that will improve our understanding of Parkinson’s so that better treatments can be developed in the future. read more

Biodegradable nanoreactors demonstrate ROS shielding in human-complex-I-deficient fibroblasts

9 July 2018 Researchers of the Radboudumc and colleagues have successfully developed enzyme-loaded polymersomal nanoreactors capable of undergoing cellular integration in a controlled fashion and, subsequently, function as synthetic organelles. read more